Advertisement

Topics

Teva's application for expanded use of APL drug granted priority review

05:42 EDT 13 Sep 2017 | SmartBrief

Teva Pharmaceutical's supplemental new drug application for the combined use of Trisenox, or arsenic trioxide, with retinoic  -More

Original Article: Teva's application for expanded use of APL drug granted priority review

NEXT ARTICLE

More From BioPortfolio on "Teva's application for expanded use of APL drug granted priority review"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...